Events
Lhasa Limited hosts and attends events throughout the year. Details of specific events are available below.
Sign up for more events from Lhasa LimitedWorkshopFree
2021 Webinar | Why you should consider controlling your potentially mutagenic impurities outside the lab
24 June 2021, Online
We are delighted to have Andrew Teasdale PhD presenting within this webinar; Why you should consider controlling your potentially mutagenic impurities outside the lab.
Andrew is currently the chair of AstraZeneca’s Impurity Advisory Board and has a wealth of knowledge developed over the last 20 years of working within the pharmaceutical industry. He is a leading AZ expert for a number of key impurity areas, including mutagenic impurities (MIs).
Featured
WebinarFree
All upcoming events
August
2021 (11th) World Congress on Alternatives and Animal Use in the Life Sciences
Virtual Conference
23 August 2021
July
2021 Toxicology Forum - Virtual Summer Meeting
Virtual Conference
27 July 2021
At the 2021 Toxicology Forum Virtual Summer Meeting Dr. David Ponting, Lhasa Senior Scientist will be chairing a session on Tuesday 2nd August titled, N-Nitrosamine Impurities in Pharmaceuticals - Potency, Prediction, and Acceptable Limits.
2021 Webinar | Lhasa Limited Nitrosamine Impurity Workshop
WorkshopFree
14 July 2021
Join us as we investigate the new ANVISA guidance for N-Nitrosamines from ANVISA, Industry - GSK and Libbs Farmacêutica - and Lhasa representatives.
June
2021 Webinar | Why you should consider controlling your potentially mutagenic impurities outside the lab
WorkshopFree
24 June 2021
We are delighted to have Andrew Teasdale PhD presenting within this webinar; Why you should consider controlling your potentially mutagenic impurities outside the lab.
Andrew is currently the chair of AstraZeneca’s Impurity Advisory Board and has a wealth of knowledge developed over the last 20 years of working within the pharmaceutical industry. He is a leading AZ expert for a number of key impurity areas, including mutagenic impurities (MIs).
